Preemptive interferon-α treatment could protect against relapse and improve long-term survival of ALL patients after allo-HSCT

Relapse was the major cause of treatment failure in patients with acute lymphoblastic leukemia (ALL) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We aimed to identify the efficacy and safety of preemptive interferon-α (IFN-α) treatment in ALL patients who had minimal residua...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Sining, Luo, Xueyi, Zhang, Xiaohui, Xu, Lanping, Wang, Yu, Yan, Chenhua, Chen, Huan, Chen, Yuhong, Han, Wei, Wang, Fengrong, Wang, Jingzhi, Liu, Kaiyan, Huang, Xiaojun, Mo, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677364/
https://www.ncbi.nlm.nih.gov/pubmed/33214615
http://dx.doi.org/10.1038/s41598-020-77186-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677364/
https://www.ncbi.nlm.nih.gov/pubmed/33214615
http://dx.doi.org/10.1038/s41598-020-77186-9

Ejemplares similares